Name | Type | Posted | Actions |
|---|---|---|---|
PBS Antifungal 2026 SSN_Final.docx | DOCX | May 21, 2026 |
RFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections
Contact and place of performance
Audrey Glover
USA
The Center for the Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to collect feedback from current and prospective antifungal development partners. Information obtained from this RFI will serve as continued planning for potential future...
View moreThe Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Request for Information (RFI) to gather feedback from current and prospective antifungal development partners. This Sources Sought notice, identified by solicitation number RFI-MCM-TDRFI-BARDA-2026, aims to strengthen the agency's understanding of the current and future marketplace for medical countermeasures addressing drug-resistant fungal infections. Information collected through this process will assist in planning potential future acquisitions and programs while assessing the qualifications and capabilities of both Small Businesses (SB) and Other than Small Businesses (OTSB).
The performance of any resulting activities is designated for the United States, and there is no set-aside assigned to this notice. Interested parties must submit responses by the deadline of June 21, 2026. The RFI was published on May 21, 2026, and includes one attachment titled PBS Antifungal 2026 SSN_Final.docx. Audrey Glover serves as the primary point of contact for this inquiry.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.